Medical Devices & Pharma Articles
MHRA updates guidance on the risks of depression and sexual dysfunction for patients using finasteride or dutasteride for hair loss and prostate disorders
Eli Lilly is investing an additional US$4.5bn to expand its Lebanon, Indiana sites for GLP-1 drugs and genetic medicines amid surging demand growth
Pharmaceutical giant restarts investment in Cambridge and Macclesfield facilities following government deal, securing thousands of jobs across both sites
Top stories include Ecolab's AI Water intelligence, KPMG's CEO report, Colgate-Palmolive’s targets, Novartis' antimalarial drug & Merck Group’s bio-solvent
PwC’s 2026 report reveals women’s health as a US$600bn growth market, underfunded yet expanding beyond reproductive care into a major clinical opportunity
WHO has prequalified Novartis and MMV’s Coartem Baby, the first antimalarial for infants two to five kg, addressing a critical gap in African malaria care
Reltio's VP Communications, Kevin Keenan, shares his thoughts on the rise of direct-to-consumer drug sales
Huawei is returning to the professional running space with new wearables, mobiles and AI innovations, all unveiled at the Madrid Now is Your Run launch